Rothschild Investment LLC Trims Stake in Elevance Health, Inc. $ELV

Rothschild Investment LLC lessened its position in Elevance Health, Inc. (NYSE:ELV) by 54.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 335 shares of the company’s stock after selling 402 shares during the period. Rothschild Investment LLC’s holdings in Elevance Health were worth $130,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. WPG Advisers LLC purchased a new stake in Elevance Health in the 1st quarter worth about $29,000. BOK Financial Private Wealth Inc. bought a new position in shares of Elevance Health during the second quarter valued at approximately $32,000. Glass Jacobson Investment Advisors llc raised its holdings in shares of Elevance Health by 400.0% in the second quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock worth $39,000 after buying an additional 80 shares during the period. Saudi Central Bank purchased a new stake in shares of Elevance Health in the first quarter worth approximately $40,000. Finally, Trust Co. of Toledo NA OH bought a new stake in shares of Elevance Health during the 2nd quarter worth approximately $43,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Elevance Health Stock Performance

ELV stock opened at $316.84 on Thursday. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $458.75. The business has a 50-day moving average price of $330.57 and a 200 day moving average price of $339.47. The company has a market capitalization of $70.41 billion, a P/E ratio of 12.95, a PEG ratio of 1.23 and a beta of 0.60. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56.

Elevance Health (NYSE:ELV) last issued its earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.03 by $1.00. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The company had revenue of $50.09 billion for the quarter, compared to analysts’ expectations of $49.26 billion. During the same period in the prior year, the business earned $8.37 EPS. The firm’s quarterly revenue was up 12.0% on a year-over-year basis. As a group, equities research analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Friday, December 5th will be issued a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Friday, December 5th. Elevance Health’s dividend payout ratio (DPR) is presently 27.96%.

Analysts Set New Price Targets

ELV has been the topic of a number of recent analyst reports. Robert W. Baird reduced their target price on Elevance Health from $492.00 to $297.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Weiss Ratings restated a “sell (d+)” rating on shares of Elevance Health in a report on Monday. Guggenheim lifted their price objective on shares of Elevance Health from $360.00 to $398.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. Mizuho lowered their price objective on shares of Elevance Health from $420.00 to $400.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Finally, UBS Group dropped their target price on shares of Elevance Health from $435.00 to $425.00 and set a “buy” rating on the stock in a research note on Friday, September 5th. Twelve equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $397.33.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.